Regenerative medicine has given patients three major biological tools: platelet-rich plasma (PRP), exosomes, and mesenchymal stem cell (MSC) therapy. All three are used in protocols intended to support tissue repair and inflammatory balance — but they work differently, suit different patients, and carry very different cost profiles. This guide breaks down the honest clinical picture for each.
PRP is the most established of the three. It is prepared from the patient's own blood: a small draw is centrifuged to concentrate platelets — which are rich in growth factors like PDGF, TGF-β, and VEGF — into a serum that is then injected directly into a target area.
PRP works by delivering a high local concentration of healing signals to injured tissue. Because it comes from the patient's own blood, there is no rejection risk. It is well-studied in orthopedics (especially for knee osteoarthritis, Achilles tendinopathy, and rotator cuff injuries) and increasingly in aesthetics (hair restoration, skin rejuvenation).
Best candidates for PRP: Patients with localized, early-stage orthopedic injuries or those seeking aesthetic applications like hair growth and facial skin renewal. PRP is also often used as a complement to MSC therapy to enhance local healing signals at injection sites.
Limitations: PRP is highly local — it doesn't address systemic inflammation or whole-body regeneration. Its effectiveness also depends heavily on the patient's platelet count and baseline health. Older patients and those on certain medications may have lower platelet activity.
Exosomes are nanoscale membrane-bound vesicles secreted by cells — particularly by MSCs — that carry proteins, RNA, and signaling molecules. They are increasingly understood to be the primary mechanism through which stem cells communicate with other cells and trigger healing cascades.
The commercial appeal of exosomes lies in their shelf stability and scalability: unlike live stem cells, exosomes can be manufactured, concentrated, freeze-dried, and stored for months without significant loss of activity. They are also smaller than cells, allowing IV-delivered preparations to penetrate tissues that whole cells cannot reach as easily.
Best candidates for exosomes: Patients seeking systemic anti-aging and longevity protocols, those who want the benefits of MSC-derived signaling without live cells, and patients with neurological conditions where CNS penetration matters. Exosomes are also an excellent option for aesthetics — particularly skin and scalp rejuvenation.
Limitations: The regulatory landscape for exosomes is still evolving. Quality and potency vary significantly between providers. Look for products with documented particle counts, protein markers, and GMP certification.
MSC therapy delivers live, biologically active cells that can home to sites of injury and inflammation, modify the local immune environment, release their own exosomes and growth factors, and in some cases differentiate into tissue-specific cells. It is the most comprehensive of the three interventions.
At Renuvia, MSCs are derived from umbilical cord tissue (Wharton's jelly) — a source that yields younger, more potent cells than autologous options. Systemic protocols are administered by IV infusion; targeted protocols for joints use ultrasound-guided injection.
Best candidates for MSC therapy: Patients with systemic inflammatory conditions (autoimmune disease, metabolic syndrome), moderate-to-advanced osteoarthritis, neurological conditions, or those pursuing comprehensive longevity protocols. MSC therapy provides the widest biological activity of the three options.
Limitations: MSC therapy involves more regulatory oversight, higher cost, and more complex logistics than PRP or exosomes. All cells must meet stringent GMP standards and traceability documentation.
| Factor | PRP | Exosomes | MSC Therapy |
|---|---|---|---|
| Source | Patient's own blood | MSC-derived, donor | Donor MSCs (cord tissue) |
| Mechanism | Local growth factor delivery | Cell-to-cell signaling | Immune modulation + signaling + differentiation |
| Systemic effect | Minimal | Moderate | Strong |
| Best application | Local injury, aesthetics | Anti-aging, neurology, aesthetics | Autoimmune, OA, longevity, neurological |
| Session duration | 30–60 min | 45–90 min | 60–120 min |
| Relative cost | $ | $$ | $$$ |
| Evidence base | Extensive | Growing rapidly | Extensive (systemic use) |
Yes — and combination protocols are often more effective than any single modality. A common Renuvia approach for advanced knee osteoarthritis, for example, is an IV MSC infusion (systemic anti-inflammatory effect) combined with an intra-articular injection of MSCs plus PRP (local regenerative signal). For longevity protocols, MSC infusion plus exosome IV can target both cellular and intercellular dimensions of aging simultaneously.
Our physicians will review your case and give you an honest recommendation — no pressure, no one-size-fits-all approach.
Book a Free Consultation →Renuvia provides medical evaluations and physician-led regenerative medicine protocols based on individual suitability. Regenerative therapies may not be appropriate for every patient. Outcomes vary and no specific result is guaranteed. Some therapies may be considered investigational or may not be approved by regulatory agencies such as the FDA for certain uses. All treatment decisions require physician evaluation, informed consent, and compliance with applicable local regulations.
La medicina regenerativa ha dado a los pacientes tres herramientas biológicas principales: el plasma rico en plaquetas (PRP), los exosomas y la terapia con células madre mesenquimatosas (MSC). Las tres buscan apoyar la curación y reducir la inflamación, pero funcionan de manera diferente.
El PRP es el más establecido de los tres. Se prepara a partir de la propia sangre del paciente: se centrifuga para concentrar las plaquetas — ricas en factores de crecimiento — en un suero que se inyecta directamente en la zona objetivo. Es especialmente útil para lesiones ortopédicas localizadas y aplicaciones estéticas como la restauración capilar.
Los exosomas son vesículas nanométricas secretadas por las células — particularmente por las MSC — que transportan proteínas, ARN y moléculas de señalización. A diferencia de las células vivas, los exosomas pueden almacenarse durante meses sin perder actividad significativa, lo que los hace escalables y versátiles para protocolos sistémicos.
La terapia con MSC entrega células vivas biológicamente activas que pueden dirigirse a zonas de lesión e inflamación, modificar el ambiente inmunológico local y liberar sus propios exosomas y factores de crecimiento. Es la intervención más completa de las tres.
| Factor | PRP | Exosomas | Terapia MSC |
|---|---|---|---|
| Fuente | Sangre del paciente | Derivado de MSC, donante | MSC de donante (cordón umbilical) |
| Mecanismo | Factores de crecimiento locales | Señalización celular | Inmunomodulación + señalización + diferenciación |
| Efecto sistémico | Mínimo | Moderado | Fuerte |
| Mejor aplicación | Lesión local, estética | Antienvejecimiento, neurología | Autoinmune, OA, longevidad, neurológico |
| Costo relativo | $ | $$ | $$$ |
Sí, y los protocolos combinados suelen ser más efectivos que cualquier modalidad individual. El enfoque adecuado depende de tu condición específica, historial médico y objetivos. Nuestros médicos revisarán tu caso durante la consulta de descubrimiento.
Nuestros médicos revisarán tu caso y te darán una recomendación honesta — sin presión, sin un enfoque único para todos.
Reservar Consulta Gratuita →Renuvia proporciona evaluaciones médicas y protocolos de medicina regenerativa dirigidos por médicos según la idoneidad individual. Las terapias regenerativas pueden no ser apropiadas para todos los pacientes. Los resultados varían y no se garantiza ningún resultado específico. Algunas terapias pueden considerarse investigacionales o no estar aprobadas por agencias regulatorias como la FDA para ciertos usos. Todas las decisiones de tratamiento requieren evaluación médica, consentimiento informado y cumplimiento de las regulaciones locales aplicables.
אקסוזומים, PRP ותאי גזע שייכים לאותה משפחה רגנרטיבית, אך הם אינם אותו טיפול. ההבדל נמצא במקור הביולוגי, בעומק האיתות ובסוג התגובה שאנו מנסים לעורר.
PRP מופק מדם המטופל ומרכז טסיות דם המכילות גורמי גדילה. הוא מתאים במיוחד לשיקום שיער, אסתטיקה, גידים ומפרקים במקרים נבחרים.
אקסוזומים הם ננו-שלפוחיות שמעבירות מסרים ביולוגיים בין תאים. הם אינם תאים חיים, אך יכולים לשאת חלבונים, RNA וגורמי איתות שמכוונים תהליכי תיקון.
MSC חיים יכולים להגיב לסביבה הדלקתית, להפריש גורמים שונים לאורך זמן ולתמוך במודולציה חיסונית. לכן הם נבחנים לעיתים במטרות מערכתיות או אורתופדיות מורכבות יותר.
הבחירה אינה תפריט, אלא החלטה רפואית המבוססת על מטרות, בדיקות, היסטוריה רפואית ומידת ההתאמה.
לקביעת שיחת היכרות →Renuvia מספקת הערכות רפואיות ופרוטוקולים ברפואה רגנרטיבית בהובלת רופאים בהתאם להתאמה אישית. טיפולים רגנרטיביים אינם מתאימים לכל מטופל. התוצאות משתנות ואין הבטחה לתוצאה מסוימת. חלק מהטיפולים עשויים להיחשב ניסיוניים או לא להיות מאושרים על ידי רשויות רגולטוריות כגון ה-FDA לשימושים מסוימים. כל החלטת טיפול דורשת הערכת רופא, הסכמה מדעת ועמידה ברגולציה המקומית החלה.